Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB09339ApprovedWithdrawnProtein Based Therapies
Indium In-111 imciromab pentetate is a mouse monoclonal antibody labelled with the radioisotope Indium-111 which was used for cardiac imaging under the trade name Myoscint, but was withdrawn in 1993.
- Also known as
- Indium (111In) imciromab pentetate · Indium In 111 imciromab pentetate · Indium In-111 myoscint · Myoscint indium In-111
Resolves to
Compound
Which companies are running trials of Indium In-111 imciromab pentetate, in which indications and phases, and which of those programs are still active?